Efficacy and safety of apatinib monotherapy for patients with advanced breast cancer: a systematic review and meta-analysis

BACKGROUND: Patients with advanced breast cancer usually have poor prognosis. Apatinib is a small-molecule tyrosine kinase inhibitor, and the reports regarding the efficacy and safety of apatinib monotherapy for advanced breast cancer in the current literature are controversial. Therefore, we perfor...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Xuchen, Hu, Xuhua, Yi, Tongbo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9376484/
https://www.ncbi.nlm.nih.gov/pubmed/35978823
http://dx.doi.org/10.3389/fonc.2022.940171

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9376484/
https://www.ncbi.nlm.nih.gov/pubmed/35978823
http://dx.doi.org/10.3389/fonc.2022.940171

Ejemplares similares